4//SEC Filing
Feider Stephen 4
Accession 0001415889-25-023898
CIK 0001674632other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 6:15 PM ET
Size
8.5 KB
Accession
0001415889-25-023898
Insider Transaction Report
Form 4
Feider Stephen
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-05$5.10/sh+100$510→ 44,141 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-09-05−100→ 99,595 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (100 underlying) - Sale
Common Stock
2025-09-05$21.00/sh−100$2,100→ 44,041 total
Footnotes (2)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- [F2]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048588
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 6:15 PM ET
- Size
- 8.5 KB